Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: December 2014
-
By Ralph Cox* & Kinjal Kondhia** — After a series of papers, reports and consultations on the scope of the research exemptions to patent infringement stretching over 10 years, section 60 of the Patents Act 1977 was finally amended on 1 October 2014 by the introduction of new subsections 6D to 6G. These subsections clarify the…
-
By Andrew Williams — Last year, Sandoz filed a declaratory judgment action against Amgen and Roche related to its etanercept biosimilar drug product, which it developed to compete with Amgen's Enbrel® TNF inhibitor. Specifically, Enbrel® is a receptor fusion protein that binds TNF-α, thereby acting as a decoy receptor molecule. In the Sandoz complaint, it…
-
By Michael Borella — DDR Holdings ("DDR") sued Hotels.com and several other defendants in the United States District Court for the Eastern District of Texas, alleging infringement of U.S. Patent Nos. 6,993,572 and 7,818,399. DDR eventually settled with all defendants except for National Leisure Group, Inc. ("NLG") and Digital River, Inc. After a trial, the…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Reckitt Benckiser Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA Inc.1:14-cv-01451; filed December 2, 2014 in the District Court of Delaware • Plaintiffs: Reckitt Benckiser Pharmaceuticals Inc.; RB Pharmaceuticals Ltd.; MonoSol Rx LLC• Defendant: …
-
December 8, 2014 – "Demonstrating Patent Eligibility Post-Alice Corp. Decision — Navigating the Nuances and Leveraging Guidance From Federal Circuit and PTAB Opinions" (Strafford) – 1:00 to 2:30 pm (EST) December 10, 2014 – European Patent Reform Forum (Managing Intellectual Property) – San Jose, CA December 11, 2014 – "Is Inequitable Conduct Making Its Comeback?"…
-
American Conference Institute (ACI) will be holding an Advanced Summit on Life Sciences Patents on January 13-14, 2015 in New York, NY. ACI faculty will offer sessions on: • Protecting patents in light of increasingly strict § 101 patentability standards post-Myriad and USPTO patent eligibility guidelines• Demystifying the doctrine of obviousness-type double patenting and analyzing…
-
Strafford will be offering a webinar/teleconference entitled "Evolving PTAB Trial Practice: Navigating Complex Procedural Rules — Strategically Using Routine and Additional Discovery, Requests for Joinder, and Motions to Amend" on December 15, 2014 from 1:00 to 2:30 pm (EST). Greg H. Gardella and Scott A. McKeown of Oblon Spivak McClelland Maier & Neustadt will provide…
-
The American Bar Association (ABA) Center for Professional Development and Section of Intellectual Property Law will be offering a live webinar entitled "Strategic Considerations Before Kick-Starting an IPR" on December 16, 2014 from 1:00 to 2:30 pm (ET). Jennifer Lee Bailey, Kim E. Choate, Margaret McInerney Welsh, and Thomas Victor Miller discuss factors that a…
-
The Federal Circuit Bar Association (FCBA) will be holding a panel discussion webinar entitled " Appealing to the Federal Circuit From PTAB Decisions in AIA Review Proceedings" on December 11, 2014 from noon to 1:00 pm (EST). Scott Weidenfeller of the USPTO Office of the Solicitor, John Dragseth of Fish & Richardson P.C., and Timothy…
-
By Andrew Williams — Just what does it take to amend your claims during an IPR proceeding before the PTAB? Of course, the America Invents Act ("AIA") specifically provides that Patent Owners may file one motion to amend the claims. AIA, § 316(d)(1). However, most people in the patent community are well aware that the…
Patent Docs 